Skanska signs contract with Seagen to build facility in Washington, USA for USD 215 M, about SEK 2.25 billion

Skanska has finalized a contract with Seagen to construct a 25,000 square meter biomanufacturing facility for the global biotechnology company. The facility will include manufacturing, storage, shipping, office, and café space in Everett, Washington, USA. The contract is worth USD 215 M, about SEK 2.25 billion, which will be included in the U.S. order bookings for the third quarter, 2023. 

Seagen announced their plans to build the project in April 2022. Construction is underway and completion is anticipated for Q4, 2024.

For further information please contact:

Daniela Arellano, Communications Director, Skanska USA, tel +1 213 317 4977

Olof Rundgren, Media Relations Manager, Skanska AB, tel +46 (0)10 448 67 94

Direct line for media, tel +46 (0)10 448 88 99

This and previous releases can also be found at www.skanska.com.

Skanska Group uses knowledge & foresight to shape the way people live, work, and connect. Over 135 years in the making, we’re one of the world’s largest project development and construction companies, with 2022 revenue totaling SEK 162 billion. We operate across select markets in the Nordics, Europe and USA. Together with our customers and the collective expertise of our 28,000 teammates, we create innovative and sustainable solutions that support healthy living beyond our lifetime.